// App-Quantinova.ai

OC 23.2 : Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: data from the REVERSE cohort study

Researchers

Presenter

  • Y. Xu

Principal Investigators

  • F. Khan

  • M. Kovacs

  • M. Righini

  • M. Carrier

  • S. Kahn

  • P. Wells

  • D. Anderson

  • M. Crowther

  • R. White

  • M. Rodger

  • G. Le Gal

Medical Centers

  • University of Ottawa, Ottawa, ON, Canada

  • Division of Hematology, Department of Medicine, University of Western Ontario, London, Ontario, Canada, London, Ontario, Canada

  • University of Geneva, Ottawa, Ontario, Canada

  • Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland

  • University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

  • Division of Internal Medicine, Department of Medicine, McGill University, Montreal, Québec, Canada, Montreal, Quebec, Canada

  • Department of Medicine, The Ottawa Hospital Research Institute at the University of Ottawa, Ottawa, Canada., Ottawa, Canada

  • Dalhousie University, Halifax, Nova Scotia, Canada.

  • University of Montreal, Montreal, QC, Canada

  • McMaster University, Internal Medicine, Hamilton, Canada

  • University of California, Davis, Davis, California, United States

  • Department of Medicine, McGill University Health Center, Montréal, Quebec, Canada., Montreal, QC, Canada

Locations

  • Canada

  • Switzerland

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • D-dimer

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved